Over 30 years ago, Boehringer Ingelheim started developing and producing biopharmaceuticals as one of the first companies worldwide. Biopharmaceuticals are produced by using either mammalian cell cultures or microorganisms such as bacteria or yeast. They are proteins of great complexity, consisting of dozens, even hundreds, of amino acids. With these biotechnically produced medicines, we aim to offer better health and quality of life to patients suffering from serious diseases. Our success is the driving force for further innovation.